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Runx2–Cbfa1, a Runt transcription factor, plays important roles during skeletal development. It is required for differentiation and function
of osteoblasts. In its absence, chondrocyte hypertrophy is severely impaired and there is no vascularization of cartilage templates during
skeletal development. These tissue-specific functions of Runx2 are likely to be dependent on its interaction with other proteins. We have
therefore searched for proteins that may modulate the activity of Runx2. The yeast two-hybrid system was used to identify a groucho
homologue, Grg5, as a Runx2-interacting protein. Grg5 enhances Runx2 activity in a cell culture-based assay and by analyses of postnatal
growth in mice we demonstrate that Grg5 and Runx2 interact genetically. We also show that Runx2 haploinsufficiency in the absence of Grg5
results in a more severe delay in ossification of cranial sutures and fontanels than occurs with Runx2 haploinsufficiency on a wild-type
background. Finally, we find shortening of the proliferative and hypertrophic zones, and expansion of the resting zone in the growth plates of
Runx2+/Grg5/mice that are associated with reduced Ihh expression and Indian hedgehog (Ihh) signaling. We therefore conclude that Grg5
enhances Runx2 activity in vivo.
D 2004 Elsevier Inc. All rights reserved.Keywords: Grg5; Runx2; Yeast two-hybrid; Ihh; Growth plate; MouseIntroduction
Runx2–Cbfa1, a DNA-binding transcription factor, plays
several key roles in skeletal development (Karsenty and
Wagner, 2002; Olsen et al., 2000). It is essential for the
differentiation of osteoblasts, critical for chondrocyte differ-
entiation to hypertrophy, and is important for bone matrix
production by mature osteoblasts (Ducy et al., 1997; Inada et
al., 1999; Kim et al., 1999; Komori et al., 1997; Otto et al.,
1997). Haploinsufficiency of Runx2 causes cleidocranial
dysplasia (CCD) in mice and humans (Huang et al., 1997;
Mundlos et al., 1997; Otto et al., 2002). In Runx2 null mice,
lack of osteoblastic differentiation results in the absence of0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.03.003
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School, 240 Longwood Avenue, Boston, MA 02215. Fax: +1-617-432-
0638.
E-mail address: bjorn_olsen@hms.harvard.edu (B.R. Olsen).bone formation, and chondrocytes in most cartilage tem-
plates fail to undergo hypertrophy, with the notable excep-
tion of distal limb cartilages. Overexpression of Runx2 in
chondrocytes promotes hypertrophy resulting in premature
endochondral ossification (Takeda et al., 2001; Ueta et al.,
2001). Overexpression of a dominant-negative form of
Runx2 in osteoblasts inhibits bone formation (Ducy et al.,
1999), while overexpression of Runx2 in osteoblasts also
leads to bone loss (without increasing osteoclastogenesis),
suggesting that Runx2 at inappropriately high levels can
inhibit the process of maturation of osteoblasts to osteocytes
(Geoffroy et al., 2002; Liu et al., 2001).
Runx2 is one of three Runt transcription factors in
mammals (Speck et al., 1999). Runx1 is important in
hematopoiesis and Runx3 may play a role as a gastrointes-
tinal tumor suppressor and possibly a transcription factor
during neurogenesis (Castilla et al., 1996; Guo et al., 2002;
Inoue et al., 2002; Levanon et al., 2002; Li et al., 2002). The
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Drosophila Brother (Bro) and Big-Brother (Bgb) (Adya et
al., 2000; Tahirov et al., 2001). The association of Cbfh with
Runx proteins facilitates their DNA binding (Tahirov et al.,
2001). The phenotype of Cbfb null mice is similar to that of
Runx1-deficient mice (Wang et al., 1996). Mice that express
a hypomorphic allele of Cbfb or mice that are Cbfb null but
are partially rescued by carrying a Cbfb transgene under the
control of promoters expressed by hematopoietic cells ex-
hibit a severe skeletal phenotype similar to that of Runx2 null
mice (Kundu et al., 2002; Miller et al., 2002; Yoshida et al.,
2002). These findings are consistent with the in vitro
evidence of heterodimerization between Cbfh and Runx
proteins and support the notion that Cbfh plays an important
role in regulating the activity of Runx2.
Runx2 is expressed in preosteoblasts, osteoblasts, pre-
chondrocytes, and prehypertrophic chondrocytes. Its biolog-
ical functions in chondrocytes and osteoblasts are clearly
distinct, but the basis for this tissue specificity is unknown.
At the molecular level, the tissue specificity of Runx2
function is likely to be dependent on its interaction with
other transcription complex partners. In a search for addi-
tional Runx2-interacting proteins, we identified Grg5 (grou-
ucho related gene 5) as an interacting protein and therefore a
potential co-regulator of the activity of Runx2.
Groucho-related genes (Grgs, also-called TLEs, trans-
ducer-like Espl) are members of a family of co-regulators
that do not bind to DNA directly but modulate the activities
of DNA-binding transcription factors (Chen and Courey,
2000; Stifani et al., 1992). Based on their primary structure,
they can be divided into two subgroups. Members of one
subgroup, Grg1–4, resemble Drosophila Gro, containing an
N-terminal glutamine-rich (Q) domain, a glycine/proline-
rich (G/P) region, a central variable region (CnC), and C-
terminal WD-40 repeats. Members of this subgroup have
been shown to function as transcriptional corepressors.
Members of the other subgroup, including Grg5, contain
only the N-terminal Q and G/P-rich domains. In contrast to
Grg1–4, Grg5 is a positive modulator of Lef/Tcf transcrip-
tion factors (Brantjes et al., 2001; Cavallo et al., 1998;
Roose et al., 1998).
Grg5 is expressed ubiquitously in mouse tissues. Half of
Grg5 null mice exhibit a growth defect that affects the
skeletal system and is associated with reduced Indian
hedgehog (Ihh) signaling in the growth plates of long bones
(Mallo et al., 1993, 1995; Miyasaka et al., 1993; Wang et al.,
2002). Here we report that Grg5 interacts with Runx2 and
acts as a positive regulator of Runx2 activity in vitro. To
study the in vivo effects of this interaction, we crossbred
Runx2 heterozygous mice with Grg5 heterozygous and null
mice. Reduced Runx2 function exacerbates the body and
skeletal growth defect in Grg5 null mice. The lack of Grg5
activity aggravates defective membranous bone formation in
Runx2 heterozygous mice and causes a severe long bone
growth plate defect associated with a profound reduction in
Ihh signaling.Materials and methods
Yeast two-hybrid screening
ADupLEX-Akyeast two-hybrid kit was purchased (Ori-
gene Technologies Inc., MD) and used in this study.
Bait construction
We constructed a LexA-Runx2 bait based on previously
published data and two initial observations during this study.
First, we made a LexA-Runx2 construct. A pair of primers,
5V CCG GGATCC ATC CGA GCA CCA GCC GGC GCT
TC 3V and 5V CCG CTC GAG TCA ATA TGG CCG CCA
AAC AGA CTC 3V, was used to amplify Runx2 cDNA from
a pool of mouse E13.5 embryonic cDNAs reversely tran-
scribed from total RNA. This cDNA, flanked by BamH1 and
XhoI restriction enzyme sites, covered the entire coding
region of Runx2, from the N-terminal sequence DPSTSRRF
to the carboxyl end. The cDNAwas inserted into pBluescript
vector and then moved to the bait vector pEG202 resulting in
an in-frame fusion of Runx2 with LexA DNA binding
protein. In initial experiments, we observed that transform-
ants containing the constructed plasmid grew poorly on the
selective media. The mechanism of toxicity was unclear and
was not studied further. Second, we made the chance
observation that the toxicity of the bait could be alleviated
by mutations in the Runt domain. Two nucleotide substitu-
tions, accidentally generated by PCR, caused two amino acid
changes in the Runt domain; a lysyl residue was replaced by
arginine and a threonyl residue was replaced by isoleucine.
No mutations were found in other regions of this PCR
product. A bait containing Runx2 with these two mutations
in the Runt domain was no longer toxic, but unfortunately
autoactivated the reporter LacZ. To overcome this autoacti-
vation, we expanded an 18-residue alanyl stretch in the N-
terminal portion of Runx2 to 27 alanyl residues. An alanyl
expansion in Runx2 can cause cleidocranial dysplasia,
suggesting loss of Runx2 activity in humans (Mundlos et
al., 1997; Thirunavukkarasu et al., 1998). In addition, the
presence of 27 alanyl residues in murine Runx2 abolishes
transcriptional activity in luciferase reporter assays (Thiru-
navukkarasu et al., 1998). Therefore, the DNA fragment
encoding the18 alanyl residues in Runx2 was replaced with a
DNA segment encoding an expanded 27 alanyl residues. The
final bait used in the screening, LexA-Runx2mut27,
contained a 27-residue expanded alanyl stretch at the N-
terminal part of Runx2 and the above two base substitutions
in the Runt domain. The LexA-Runx2mut27 bait was
utilized to search for Runx2-interacting proteins using an
embryonic cDNA E13.5 library.
E13.5 cDNA library
Total RNAs were extracted from E13.5 embryos by the
guanidine thiocyanate method followed by ultracentrifuga-
tion (Sambrook et al., 1989). Polyadenylated RNA was
purified from total RNAs using an oligodT column (Prom-
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synthesis kit (Stratagene, CA), ligated to EcoRI adaptors,
and inserted into pJG4–5 plasmid containing the transcrip-
tion activation domain B42. The ligation mixture was
desalted and electroporated into Escherichia coli strain
XL-1Blue. A cDNA library of 2.0  106 independent trans-
formants was obtained.
Construction and screening of yeast library
Both LexA-Runx2mut27 bait plasmid and a reporter
plasmid pSH18–34 (LacZ reporter) were transformed into
yeast host EGY48 (bait host). The cDNA plasmid library
was used to transform the bait host. About 5  105 yeast
transformants were obtained and were used for the screening
for Runx2-interacting proteins.
The yeast cells, containing the bait plasmid, the LacZ
reporter plasmid, and the cDNA library plasmids, were
incubated in galactose-containing selective media for 2
h and then plated on galactose and X-gal media in the
absence of leucine supplement. The blue colonies that grew
on those media were streak-purified and tested again for
growth in the absence of leucine supplement and for h-
galactosidase (LacZ) activity. Plasmids from positive colo-
nies were extracted and transformed into the Trp E. coli
strain KC-8 to recover Trp+ prey cDNA plasmid. The
recovered plasmid cDNAs were sequenced using primers
flanking the insert. Homology searches were performed to
identify the cDNA sequences.
Cell culture, Runx2 activity assay, and
co-immunoprecipitation
COS-7 cells were maintained in DME high glucose media
supplemented with 10% FBS (Irvine Scientific, CA). The
transcriptional activity of Runx2 was assayed as luciferase
units using the 6OSE2-luc reporter. Cells were seeded at a
density of 2  104/cm2 grown overnight before transfection
so that confluency reached about 90%. Three plasmids, each
with the CMV promoter controlling the transcription of h-
galactosidase (to normalize the luciferase units), Grgs, or
Runx2, were co-transfected with a luciferase reporter plas-
mid 6OSE2-Luc into COS-7 cells using transfection reagent
GenePorter (Genome Therapeutic System, CA) according to
the manufacturer’s protocol. For the detection of protein
levels, Runx2 and Grgs were tagged at N-terminus with HA-
and FLAG-epitopes, respectively. Expression levels of the
proteins in transfected cells were examined by Western
blotting using anti-HA antibodies for Runx2 constructs
(Santa Cruz, CA) and anti-FLAG antibodies for Grg con-
structs (Sigma, MO). With the exception of the DN1–94 and
DQA48–94 Runx2 constructs, no significant differences in
levels of expression were seen among the different Runx2-
truncated proteins (Fig. 2B) and different Grgs (data not
shown). As controls for transfection, we replaced Grgs or
Runx2 plasmids with the corresponding vectors only. Thirty-
six hours later, the transfected cells were lysed with lysisbuffer (Promega, WI) after two PBS washes. The total cell
extract was centrifuged to remove cell debris and the
supernatant was collected. Luciferase activity was assayed
with the substrate kit and measured with Monolight Lumin-
ometer 2010 (Analytical Luminescence Laboratory, San
Diego, CA). For immunoprecipitation, FLAG-tagged
Grg5DN27 and HA-tagged Runx2 constructs were transient-
ly co-transfected into COS-7 cells. Cells were lysed in LIPA
buffer (25 mM Tris–HCl pH 7.5, 150 mM NaCl, 2 mM
EDTA pH 8.0, 0.5% NP-40) with protease inhibitor cocktails
(Sigma). Supernatants of cell lysates were incubated with
anti-FLAG agarose beads (Sigma) at 4jC overnight. The
agarose beads were washed with LIPA buffer three times
before boiled in loading buffer for Western blots.
Mice
Heterozygous Runx2 and Grg5 mice were obtained from
the laboratories of Dr. M. Owen and Dr. T. Gridley, respec-
tively. The Runx2 mice were first crossed with C57Bl/6 and
the heterozygotes were then mated with Grg5 heterozygotes
or homozygotes. The compound mice Runx2+/ Grg5/
were obtained from matings between Runx2+/+ Grg5+/ and
Runx2+/ Grg5+/ or Runx2+/ Grg5+/ and Runx2+/+
Grg5/. Both sexes of Runx2+/ Grg5/ were infertile, a
defect in reproduction not studied further. The mice were
housed as described (Wang et al., 2002).
Growth curves
Growth curves in this study were derived as described
(Wang et al., 2002). Briefly, mice were identified by an ear
numbering system at about 2 weeks of age. Whole body
weight was measured at least twice per week. Preliminary
plots showed that the weight increase of mice was linear with
age up to 20 days after birth and also linear between days 20
and 40, but growth rates clearly differed between these two
periods. After day 40, the growth rate appeared to be close to
zero and the body weight approached maximum. Both the
growth rates and the asymptote for weight showed great
variability between different mice. To allow individual
variability to be incorporated into the analysis, we assumed
growth parameters to be random and used the nonlinear
mixed-effects model (NLME model) for calculations (Pin-
heiro and Bates, 2000). The following logistic model was
fitted for each gender separately:
Weight ¼ A=ð1þ expðBdaysÞ=CÞ
The parameter A is the asymptotic (maximal) weight for each
individual mouse, B is the age (in days after birth) when the
weight reaches half of the maximum, C is a measure of
relative growth rate, that is, how fast the weight approaches
the maximal weight and is the difference of the numbers of
days when the weight is 1 / (1 + e1) of its maximum and the
weight is half of its maximum. The growth rate (calculated
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p (1  p) A / C, where p = weight/A is the proportion of
weight to the maximal weight. The NLME model in S+
(version 5) was used to obtain the parameter estimates.
Values for A, B, and C were assumed to vary for different
genotypes. The parameter A was assumed to be random to
account for individual variability and litter effects on growth,
that is, the mother and father of individual mice were
assumed to contribute in a random fashion (lnA normally
distributed). Both parameters B and C were assumed to be
fixed to avoid spurious results because of high intrinsic
correlation.
Skeletal staining
Three-week-old mice were CO2 euthanized, deskinned,
and eviscerated. The skeletons were then immersed for 10
days in a staining solution containing alizarin red, alcian
blue, ethanol, and acetic acid. The stained skeletons were
clarified with 1.8% KOH overnight followed by 1 week in
0.3% KOH. The stained skeletons were stored in 100%
glycerol.
Histology
Histological studies were carried out as described (Wang
et al., 2002). Briefly, the tibiae and humeri were dissected
and fixed in 4% paraformaldehyde (PFA) in PBS for 1 week
at 4jC. Decalcification took place in 0.5 M EDTA pH 7.4
(pH adjusted with citric acid powder) with a change of
solution every day. The tissues were dehydrated in an
ascending ethanol series, infiltrated with paraffin through
xylene, and embedded in the desired orientation. Samples
were cut into longitudinal 5-Am sections with a HM355
Microtome, mounted onto Superfrost Plus slides (VWR),
and dried on a heated plate at 45jC overnight. The sections
were stained with hematoxylin and eosin using a standard
protocol.
Immunohistology
Bone sections for immunostaining were deparaffinized in
xylene and rehydrated in a descending ethanol series before
being processed for immunostaining in a Biogenex automat-
ed processor. Antibodies against proliferating cellular nucle-
ar antigen (PCNA), Indian hedgehog (Ihh), Smoothened
(Smo), Patched (Ptc), and parathyroid hormone-related pep-
tide (PTHrP) were purchased from Research Antibodies
(Santa Cruz, CA). A mouse monoclonal antibody against
collagen type II was purchased from LabVision (San Diego,
CA) and used in conjunction with the MOM kit (Vector
Laboratory, CA) to decrease background staining. To com-
pare Ihh expression at the protein level in growth plates,
equivalent areas in each Ihh-immunostained section were
selected for counting of Ihh-positive cells. The Ihh-positive
cell numbers from two sections from each individual mouse,with three mice used for each genotype, were averaged and
expressed as a percentage of the number of Ihh-positive cells
in sections of Runx2+/+ Grg5+/ mice (set at 100%).
In situ hybridization
Radioactive in situ hybridization with 33P-labelled probes
on tissue sections was performed as described (Hartmann
and Tabin, 2000). The probes for Col1a1, Col2a1, Col10a1,
and Ihh were the gifts of E.J. Reichenberger, N. Fukai, S.
Apte, and A. McMahon, respectively.Results
Grg5 interacts with Runx2
A yeast two-hybrid system was used to search for
Runx2-interacting proteins. We used LexA-Runx2mut27
as the bait and a mouse E13.5 cDNA plasmid library as
the prey (see Materials and methods). Approximately 5 
105 independent yeast transformants were screened result-
ing in the isolation of over 500 candidate clones. Sequence
analysis revealed that one of these clones was isolated four
times and represented a truncated version of Grg5 (Fig.
1A). The fused target B42-Grg5DN27 contained most of
the Grg5 amino acid sequence but lacked the first 27 amino
acid residues at the N-terminus (GenBank accession num-
ber L12140). The interaction between LexA-Runx2mut27
and B42-Grg5DN27 was confirmed by transforming the
corresponding plasmids back into yeast cells with LexA-
Runx2mut27, the LacZ reporter plasmid, and B42-
Grg5DN27 (Fig. 1B). To exclude a possible effect of the
lack of the very N-terminal 27 amino acid residues of
Grg5DN27 on the interaction with Runx2, full-length Grg5
was amplified by PCR and also fused to B42. No difference
was found between the truncated Grg5DN27 and full-length
Grg5 when their plasmids were compared in yeast cells
with ‘‘full-length’’ Runx2 (LexA-Runx2mut27, data not
shown). Therefore, the first 27 amino acid residues at the
N-terminus of Grg5 are not required for the interaction
between Runx2 and Grg5 in yeast.
To examine the Grg5-interacting region in Runx2, a
series of LexA-Runx2mut27 deletion constructs was made
and tested for interactions with Grg5DN27 (Fig. 1B). The
results showed that the C-terminal portion of Runx2 was
sufficient for activation of the LacZ reporter and growth in
the absence of leucine. Moreover, the removal of the C-
terminal sequence VWRPY had no effect on the interaction
between Runx2 and Grg5DN27, a finding that contrasts
with the importance of this C-terminal sequence for the
interaction between Runt and Gro in Drosophila (Aronson
et al., 1997). In summary, the Grg5-interacting domain of
the Runx2 protein resides within the C-terminal 141 amino
acid residues but does not require the last 5 amino acid
residues.
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protein structure with Grg5 (Fig. 1C; Leon and Lobe, 1997;
Yao et al., 1998). Because both Grg3b and Grg5 are members of the subfamily of short Grg proteins, homologous to the N-
terminal region of the long Grg family members, we com-
pared their interaction with Runx2. Although yeast cells
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medium, the same region in Runx2 was clearly involved in
the interactions between Runx2 and Grg5 or Grg3b (Fig.
1B). Because Grg3b and Grg5 share 73% amino acid identity
in the middle Q- and GP-rich regions while the N- and C-
terminal regions are completely different (Fig. 1C), we
conclude that the middle portion (Q and GP domains) of
Grg5 is most likely responsible for the interaction with
Runx2.
Grg5 enhances whereas Grg3 inhibits Runx2 activity
To determine the effect of the Grg5 interaction with
Runx2, we first measured Runx2 transcriptional activity in
the absence or presence of Grg5DN27 using the 6OSE2-Luc
reporter (Fig. 2). When wild-type Runx2 was co-transfected
with Grg5DN27 into COS-7 cells, the reporter luciferase
activity was increased at least 3-fold. We further constructed
a series of Runx2 deletions to test how the Grg5-interacting
domain in Runx2 affects the transcriptional activity (Fig. 2).
Consistent with the yeast two-hybrid data, the increased
activity of Grg5DN27 was correlated with the presence of
the Grg5-interacting domain in Runx2. Without the Grg5
binding domain, no enhancement of Runx2 activity by
Grg5DN27 was seen. Similar to the yeast two-hybrid assay,
we also assayed the ability of full-length Grg5 to coactivate
Runx2. The full-length Grg5 acted like Grg5DN27 on Runx2
activation as expected except in the case of three Runx2
deletion constructs, DN1–48, DN1–94, and DC516–528,
encoding Runx2 proteins that lack the N- or C-terminal
regions. This suggests that the N-terminal 27 amino acid
residues of Grg5 may exert an inhibitory effect on Grg5
coactivation in the absence of the N- or C-terminal regions of
Runx2 (see Discussion). In contrast to Grg5 and Grg5DN27,
Grg3 repressed Runx2 transcriptional activity to background
levels (Fig. 2). However, unlike full-length Grg3, Grg3b
appeared to lack specificity in transcriptional repression
because it not only repressed the Runx2 reporter but also
reduced the activity of an internal control, h-galactosidase
(data not shown).
We also performed similar transfection assays in three
other cell lines, ROS17/2.8 (rat osteosarcoma cell line),
MC3T3-E1 (mouse osteoblastic cell line), and ADTC5
(mouse chondrogenic cell line). The results with MC3T3-
E1 cells were similar to those with COS-7 cells despite aFig. 1. Grg5 and its interaction with Runx2. (A) Grg5 nucleotide (top) and the de
L12140. The vertical arrow between nucleotides 80 and 81 (nucleotide numbers a
the upstream B42, using an adaptor oligonucleotide, 5V GAATTC GGC ACG AG
Grg3b interact with the C-terminal portion of Runx2. Diagrams of a series of LexA
length bait (top) contains an N-terminal activation domain, a glutamine and ala
expanded to 27), the Runt domain, a nuclear localization sequence (NLS), and
indicated with two asterisks. Deletion constructs were made and given designati
segments of Runx2. The C-terminal VWRPY sequence is shown at the end of the
h-galactosidase activity (blue patches) with either B42-Grg5DN27 or B42-Grg3b
(bottom) protein sequences. Amino acid residue numbers at right. The amino acid i
line above the sequences) and low at N- and C-terminal regions.low transfection efficiency (data not shown). A less striking
increase in Runx2 activity (30–50%) was observed with
both ADTC5 and ROS17/2.8 cells in the presence of Grg5.
In the case of ROS17/2.8 cells, the low enhancement could
be due to a high level of endogenous Grg repressor
proteins in this cell line (Levanon et al., 1998; Thiruna-
vukkarasu et al., 1998).
To provide biochemical evidence for a Grg5–Runx2
interaction in COS-7 cells, we used FLAG-tagged
Grg5DN27 to pull down HA-tagged Runx2 proteins in
COS-7 extracts. As expected, full-length Runx2, DN1–48,
and DC516–526 proteins were detected in protein com-
plexes pulled down with anti-FLAG agarose beads whereas
DC375–528, DC275–528, and control vectors were not
(Fig. 2B and see the legend). The co-immunoprecipitation
results support the conclusion, based on the yeast two-hybrid
assays, that there is a physical interaction between Grg5 and
Runx2.
In vivo effects of Grg5 and Runx2 interaction
To study the in vivo effects of Grg5 and Runx2 inter-
actions, we crossbred mice with gene-targeted Runx2 and
Grg5 alleles. We have previously shown that Grg5 null mice
have a skeletal growth defect associated with reduced Ihh
signaling in the growth plates (Wang et al., 2002). If Runx2
is a major target of Grg5, we hypothesized that osteoblasts
and chondrocytes would display reduced Runx2 function in
the absence of Grg5, especially in the Runx2+/ Grg5/
mouse. To generate these mice, we crossed Runx2+/
Grg5+/ animals with heterozygous Grg5+/ or homozy-
gous Grg5/ mice. Similar to the experience with Grg5
null mice (Mallo et al., 1995; Wang et al., 2002), no
abnormal embryonic or postnatal lethality was observed in
Runx2+/ Grg5/ mice. The percentage of Runx2+/
Grg5/ mice was close to the expected numbers. The
observed numbers from the crosses between Runx2+/+
Grg5+/ females and Runx2+/ Grg5+/ males were
87:200:94:70:170:60 (Mendelian ratio 1:2:1:1:2:1) for the
different genotypes (Runx2 Grg5) +/+ +/+, +/+ +/, +/+
/, +/ +/+, +/ +/, +/ /.
To study the overall growth of Runx2+/ Grg5/ mice,
we used a nonlinear statistical model as previously de-
scribed for Grg5 null mice (Wang et al., 2002) to derive the
growth curves for the six possible genotypes. We comparedrived amino acid (bottom) sequences based on GenBank accession number
t the right) indicates the site at which the Grg5 cDNAwas fused in frame to
3V, to join the B42 sequence to the Grg5DN27 sequence. (B) Both Grg5 and
-Runx2 bait constructs are shown at the left. The Runx2 portion of the full-
nine-stretch (QA27) (in which the normal polyalanine sequence has been
a PST-rich domain. The two mutations in the LexA-Runx2mut27 bait are
ons (at left) that reflect either the deleted regions or the remaining protein
full-length bait. For each bait, four yeast transformants were used to test for
as preys (results shown at right). (C) Alignment of Grg5 (top) and Grg3b
dentity between Grg5 and Grg3b is high in the Q- and G/P- domains (dashed
Fig. 2. Functional and structural interactions between Grg5 and Runx2 proteins in COS-7 cells. (A) Runx2 activity was assayed in COS-7 cells with 6OSE2-Luc reporter (diagram within bar graph at bottom) by
transient transfection. Different Runx2 constructs (diagrams at left) were co-transfected with Grgs or vector alone (colored-coded and shown within bar graph at top right). All constructs were driven by the CMV
promoter and tagged with either HA- or FLAG- epitopes (see Materials and methods). The domain structure of full-length Runx2 protein is as described in Fig. 1B. The deleted regions of Runx2 proteins in the
constructs are indicated at left; the amino acid residues are numbered according to the type II Runx2 protein sequence (GenBank accession number NM_009820). Bar graph shows luciferase units normalized to a
h-gal internal control. Three separate readings from three transfections were combined and averaged. Error bars are placed on each bar. Note, the lack of enhancement with the constructs DN1–48, DN1–94, and
DC516–528 in the presence of full-length Grg5 in comparison with Grg5DN27 (see Results and Discussion). (B) Co-immunoprecipitation of FLAG-tagged Grg5DN27 and Runx2 proteins in extracts of COS-7
cells. Top and middle panels show detection of HA-tagged Runx2 proteins (WB/HA) and FLAG-tagged Grg5DN27 (WB/FLAG) in Western blots of extracts. Bottom panel shows detection by Western blot of
Runx2 proteins in co-immunoprecipitates obtained with anti-FLAG-conjugated agarose beads. About 90% of FLAG-tagged Grg5DN27 was bound to anti-FLAG agarose, whereas only about 1% of Runx2 protein
came down with the agarose. Molecular weight markers are shown on left. The minor band under the 47-kDa marker across all the lanes in the top panel is a nonspecific band resulting from the use of an HA
polyclonal antibody; the low level of expression of DN1–94 and DQA48–94 Runx2 deletion constructs resulted in no detectable bands in the co-immunoprecipitation assay.
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littermates by measuring body weights during the first 10
weeks after birth (Fig. 3). The growth curves of wild-type
and Runx2+/+ Grg5+/ mice overlapped. Weight gain and
rate of growth in Grg5 null, Runx2+/ Grg5+/, and
Runx2+/ Grg5/ mice were significantly lower than in
wild-type animals before 4 weeks of postnatal growth (P <
0.001; Fig. 3). Consistent with the growth curves of Grg5
null mice from Grg5 heterozygous matings, we obtained
similar growth curves for Grg5 null mice (Runx2+/+) in this
study (Fig. 3). This growth defect was most severe in the
Runx2+/ Grg5/ mice, as shown also in skeletal prepa-
rations and whole body radiographs (Figs. 4A and B). A
phenotype of dwarfism and osteopenia was apparent 1 week
after birth and became severe at 2–4 weeks after birth. Most
of the affected Runx2+/ Grg5/ mice recovered to some
degree after 5 weeks of age, but nevertheless the mice
remained smaller than their littermates.Fig. 3. Growth curves of mice with Runx2+/+ Grg5+/+, Runx2+/+ Grg5+/, Runx2+
The weights of mice were measured and the weight data were fitted in a statistical m
A/(1+exp(B-days)/C)) vs. age for males and females. (B and D) Growth rate vs. age fo
and Runx2+/+ Grg5+ are essentially identical. The values for parameter B (see Mat
Grg5+/+, Runx2+/ Grg5+/, and Runx2+/ Grg5/ are all significantly differentSimilar to the findings for Grg5 null mice (Wang et al.,
2002), the severity of the growth defect in Runx2+/
Grg5/ mice varied among individuals. Despite the indi-
vidual variation, we could clearly identify the effect of the
lack of Grg5 on the phenotype associated with one copy of
Runx2. Half of Grg5 null mice (Runx2+/+) exhibit a growth
defect (Wang et al., 2002) with body weights ranging from
50% to 75% of wild-type or heterozygous Grg5 mice and
this was confirmed in this study. Only minor weight
differences were seen between wild-type and Runx2+/
Grg5+/+ mice (Fig. 3), but most of the Runx2+/ Grg5/
mice (80%) had body weights in the range of 28–75% of the
control wild-type or Runx2+/+ Grg5+/ littermates. The
weights of about 20% (21/101) of Runx2+/ Grg5/ mice
were below half the weight of wild-type littermates while
about 30% (30/101) were between 50% and 60%. These
numbers strongly suggest that having only one copy of
Runx2 in mice exacerbates the growth defect in affected/+ Grg5/, Runx2+/ Grg5+/+, Runx2+/ Grg5+/, and Runx2+/ Grg5/.
odel (see Materials and methods). (A and C) Weight (expressed as Weight =
r males and females. The curves for mice with genotypes Runx2+/+ Grg5+/+
erials and methods) of mice with genotypes of Runx2+/+ Grg5/, Runx2+/
(P < 0.001) from wild-type mice.
Fig. 4. Skeletal phenotypes of 3-week-old Runx2+/ Grg5/ mice. (A)
Skeletal staining of littermate mice of four different genotypes, Runx2+/+
Grg+/, Runx2+/ Grg5+/+, Runx2+/+ Grg5/, and Runx2+/ Grg5/.
Note the proportionately smaller skeleton in Runx2+/ Grg5/ mouse. (B)
Lateral radiographs of mice with the above genotypes. Low bone density is
seen in the radiograph of Runx2+/ Grg5/ mouse. (C) Top view of
cranial bones in mice shown in A. Note that although the separation
between the parietal and frontal bones in Runx2 heterozygous mouse is an
artifact generated during skeletal staining, the anterior fontanel is
moderately enlarged. The lack of ossification in the anterior fontanel
region and along the sagittal suture is most severe in the Runx2+/ Grg5/
mouse. The slit-like opening seen in the Runx2+/+ Grg5/ mouse is an
artifact because it was not a consistent feature of Grg5 null mice.
W.F. Wang et al. / Developmental Biology 270 (2004) 364–381372Grg5 null mice. No significant sex differences were seen
during the first 5 weeks of postnatal growth, but later the
weight differences between the female Runx2+/ Grg5/
and wild-type mice were not as large as they were in males
(Fig. 3).The growth rates for male Runx2+/ Grg5/ mice were
the lowest of all mice studied (Figs. 3A and B). The weight
gap between the male Runx2+/ Grg5/ mutant and wild-
type mice became larger with age and the mutant mice
remained smaller up to 6 months of age. This deleterious
effect of loss of Grg5 on Runx2 function continued to be
observed after 5 weeks of age in males when the growth rate
of Runx2+/ Grg5+/+ mice had caught up with wild-type
animals (Fig. 3B). For females, the weight difference
between wild-type controls and Runx2+/ Grg5/ mice
was less than that for the males (Figs. 3C and D). Consistent
with this smaller weight gap, the rate of growth of female
Runx2+/ Grg5/ mice was greater than that of wild-type
mice after 5 weeks of postnatal growth. After 2–3 months,
the weight and size of the female Runx2+/ Grg5/ mice
were similar to those of wild-type littermates (data not
shown).
In summary, the compound Runx2+/ Grg5/ mice
exhibited a dramatic phenotype of reduced growth. Inspec-
tion of the growth curves, which combine the data of all
individuals within each genotype, clearly shows that the
growth rate reduction in Runx2+/ Grg5/ mice is greater
than would be expected if Runx2 and Grg5 contributed
independently to growth (Fig. 3). Therefore, the results
strongly suggest that Runx2 and Grg5 interact genetically
in vivo and regulate postnatal growth in mice. The observa-
tions on skeletal size and bone density also suggest a specific
effect on skeletal development and growth (Figs. 4A and B).
Delayed cranial suture closure in Runx2+/ Grg5/ mice
Delayed closure of cranial sutures and hypoplastic
clavicles are prominent features of cleidocranial dysplasia
(CCD) in humans and mice resulting from haploinsuffi-
ciency of Runx2 (Huang et al., 1997; Komori et al., 1997;
Mundlos et al., 1997; Otto et al., 1997). Cranial sutures and
clavicles in Grg5 null mice are not affected. The defect in the
fontanel closure in Runx2+/ Grg5/mice was more severe
than in heterozygous Runx2mice as would be expected if the
activity of Runx2 was reduced in the absence of Grg5 (Fig.
4C). On the other hand, there was no discernible difference
between the hypoplastic clavicles of Runx2 heterozygotes
and those of Runx2 +/ Grg5/ mice. Because the clavicles
of Runx2 heterozygous mice completely lack the medial
cartilaginous anlage (Huang et al., 1997), it was not surpris-
ing that the lack of Grg5 did not exacerbate this defect.
Calvarial bones are formed by intramembranous ossifi-
cation. The more marked widening of the fontanels in
Runx2+/ Grg5/ mice (as compared to Runx2+/ mice)
suggests that osteoblastic activity is reduced (Opperman,
2000). To test this possibility, we isolated primary osteo-
blasts from the calvaria of newborn mice of various geno-
types to examine osteoblastic activity in vitro (Wang et al.,
2002). Among osteoblast cultures from wild-type, Runx2
heterozygous, Grg5 null, or Runx2+/ Grg5/ mice, no
differences were detected in their ability to form mineralized
W.F. Wang et al. / Developmental Biology 270 (2004) 364–381 373nodules (data not shown). Therefore, the delay in fontanel
closure in Runx2+/Grg5/ mice may result from a de-
crease in the number of differentiated osteoblasts rather than
a decreased ability of each osteoblast to form bone.
Growth plate defects in Runx2+/ Grg5/ mice
The small skeletons of Runx2+/Grg5/mice suggested
a growth plate defect as we have previously demonstrated in
the study of Grg5 null mice (Wang et al., 2002). Histological
analysis of the growth plates of tibia and humerus was
therefore carried out using decalcified sections. By compar-
ing these bones in Runx2+/+ Grg5+/, Runx2+/ Grg5+/+,
Runx2+/+ Grg5/, and Runx2+/ Grg5/ mice, a striking
reduction in the overall height of the growth plates as well as
a reduction in the amount of trabecular bone subjacent to the
growth plates was found in Runx2+/ Grg5/ mice (Figs.
5A–H). This abnormality was clearly more severe than the
defect seen in Runx2+/+ Grg5/mice. In Runx2+/Grg5/
mice, the zone of hypertrophic chondrocytes was clearly
thinner than in the controls (Figs. 5E–H). Although a mild
growth defect (body weight) was observed in Runx2 hetero-
zygous mice (Fig. 3), no obvious histological growth plate
defect could be seen in these mice (Figs. 5B and F).
We used immunostaining for proliferating cellular nu-
clear antigen (PCNA) to compare proliferating chondro-
cytes in tibial growth plates. In our previous study, the
percentage of PCNA-positive cells in affected Grg5 null
mice was reduced to about 75% of wild-type mice (Wang et
al., 2002). In Runx2+/ Grg5/ mice, this percentage was
even more drastically reduced to 35–45% of wild-type
mice (Figs. 5I–L). Moreover, PCNA staining allowed us to
distinguish the proliferative zone of the growth plate from
the resting and hypertrophic zones. We could clearly
determine that the reduced thickness of the growth plate
in Runx2+/+ Grg5/ mice was due to a reduction in the
thickness of the proliferative as well as the hypertrophic
zones (Figs. 5I–L). Immunostaining for collagen type II
confirmed that the hypertrophic zone of chondrocytes in
Runx2+/ Grg5/ mice was thinner than in the controls
(Figs. 5M–P). Similar observations were made for the
growth plates of humerus (data not shown).
Reduced Ihh signaling in Runx2+/ Grg5/ mice
Previously published data on the role of Runx2 in
chondrocyte differentiation suggest that it is involved in
regulating Ihh signaling (Inada et al., 1999; Kim et al., 1999;
St-Jacques and Hammerschmidt, 1999; Takeda et al., 2001).
In our study of Grg5 null mice, we found that the growth
plate defect in Grg5 null mice was associated with reduced
Ihh signaling (Wang et al., 2002). To examine Ihh signaling
in the growth plates of Runx2+/ Grg5/ mice, we per-
formed in situ hybridization for Col10a1 and Ihh (Fig. 6).
Expression of Col10a1 was similar in all mice (Figs. 6A–
D). The Ihh signal in the growth plates of both Runx2+/Grg5/ and their Grg5 null littermates was reduced com-
pared with Runx2+/+ Grg5+/ and Runx2+/ Grg5+/+ control
animals (Figs. 6E–H), but this reduction was more drastic in
Runx2+/ Grg5/ mice. We used immunohistochemistry to
further investigate the expression of Ihh and other molecules
involved in Ihh signaling such as Ptc, Smo, and PTHrP. In
contrast to the clear and robust Ihh and Smo immunostaining
in wild-type or Runx2 heterozygous sections, Ihh-positive or
Smo-positive prehypertrophic chondrocytes were signifi-
cantly reduced in Grg5 null mice while those in the
Runx2+/ Grg5/ sections were barely detectable (Fig.
7A). To semiquantitatively measure Ihh expression in growth
plates, Ihh-positive prehypertrophic chondrocytes were
counted and the numbers of such cells were compared
between the different genotypes (Fig. 7B). Despite the fact
that the number of Ihh-positive cells in Grg5 null mice was
significantly reduced (about 40% of Runx2+/+ Grg5+/
mice), a more drastic reduction was seen in Runx2+/
Grg5/ mice (about 20% of Runx2+/+ Grg5+/ mice). Ptc
protein was also reduced in a similar pattern. We also
performed immunostaining for PTHrP because it is a down-
stream target of Ihh signaling (Lanske et al., 1996; St-Jacques
and Hammerschmidt, 1999; Vortkamp et al., 1996). PTHrP
expression in Runx2+/ Grg5/ growth plates was unde-
tectable and there was a dramatic reduction in Grg5 null
growth plates compared to wild-type controls (data not
shown). Therefore, we conclude that reduced Ihh signaling
is a major cause of the severe growth plate defect in
Runx2+/ Grg5/ mice.
In an attempt to understand why trabecular bone forma-
tion is so dramatically reduced subjacent to the growth plates
of Runx2+/ Grg5/ mice, we examined osteoblasts and
osteoclasts in tissue sections by assaying for Col1a1 mRNA
expression and tartrate-resistant acid phosphatase (TRAP),
respectively. No increase in the number of TRAP-positive
osteoclasts was found subjacent to the growth plates of
Runx2+/ Grg5/ mice compared with their control litter-
mates (data not shown). Using in situ hybridization for
Col1a1, a marker for osteoblasts, the total amount of Col1a1
signal in Runx2+/ Grg5/ mice was drastically reduced,
but the intensity of the signal per cell was similar among all
the different genotypes (Figs. 6I–L). Therefore, we con-
clude, as we previously did for Grg5 null mice, that osteo-
blastic recruitment under the defective growth plates of
Runx2+/Grg5/mice is reduced, leading to the osteopenic
phenotype.Discussion
Grg5 is a coactivator of Runx2
Grg5 is one of several proteins that have been shown to
bind to the C-terminal region of Runx2 in vitro. These
proteins can act as either coactivators or corepressors and
include Grgs/Tles, Hes-1 (Hairy/Enhancer of split 1), Moz
Fig. 5. Histology of proximal tibial growth plates from 3-week-old mice with the genotypes Runx2+/+ Grg+/, Runx2+/ Grg5+/+, Runx2+/+ Grg5/, and Runx2+/ Grg5/. (A–H) Hematoxylin and eosin
staining of decalcified growth plate sections. Based on chondrocyte morphology, a growth plate can be divided into resting (R), proliferative (P), and hypertrophic zones (H). These zones, as well as the region of
trabecular bone (T) below the growth plate, are indicated along the vertical lines in E–H and labeled in E. Note the expansion of the resting zone and the thinner zones of proliferation and hypertrophy in the
Runx2+/ Grg5/growth plate. (I –L) PCNA immunostaining in growth plates. (M–P) Collagen type II immunostaining.
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Fig. 6. Expression of molecular markers in growth plates from humeri of 3-week-old mice with genotypes Runx2+/+ Grg+/, Runx2+/ Grg5+/+, Runx2+/+ Grg5/, and Runx2+/ Grg5/. (A–D) In situ
hybridization of Col10a1. No significant difference in Col10a1 expression in hypertrophic chondrocytes is seen between the different genotypes. (E–H) In situ hybridization of Ihh. Reduced Ihh expression in
Runx2+/ Grg5/ section is more dramatic than that in the Grg5 null section. Note that the Runx2+/+ Grg5/ section is from a severely affected Grg5 null mouse. (I–L) In situ hybridization of Col1a1 in
trabecular bone under the growth plates and in the secondary ossification centers above. The amount of Col1a1 mRNA is dramatically reduced in the Runx2+/ Grg5/ section.
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Fig. 7. Ihh signaling in the proximal growth plates of humeri in Runx2+/ Grg5/ mice. (A, a–d) Ihh protein detected by immunostaining using antibodies against hedgehog proteins. Ihh-positive pre-
hypertrophic chondrocytes in wild-type or Runx2 heterozygous mice occupy 2–3 cell layers in the growth plates. In contrast, barely one layer of Ihh-positive cells is present in Runx2+/+ Grg5/ mice, and Ihh-
positive cells are undetectable in Runx2+/ Grg5/ mice. (e–h) Similar immunostaining results are shown for the Ihh receptor component Smo. (B) Bar graph of relative percentage of Ihh-positive pre-
hypertrophic chondrocytes in the growth plates of Runx2+/+ Grg+/, Runx2+/ Grg5+/+, Runx2+/+ Grg5/, and Runx2+/ Grg5/ mice (sections from three mice were analyzed for each genotype). Standard
deviations are indicated by error bars. The number of Ihh-positive cells in Runx2+/ Grg5/ mice was significantly reduced in comparison with that of Runx2+/+ Grg5/ mice.
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deacetylase), and Taz (transcriptional coactivator with PDZ
motif) (Cui et al., 2003; Hess et al., 2001; Javed et al., 2000;
McLarren et al., 2000; Pelletier et al., 2002; Shirakabe et al.,
2001; Tahirov et al., 2001; Westendorf et al., 2002). In vitro
experiments show that Runx2 in association with different
members of this group of proteins can act as a transcrip-
tional activator or repressor. In the case of Grgs, the long
forms in general act as corepressors, whereas Grg5, a short
form, is a coactivator for Runx2. The full-length Grg5
behaved differently from the truncated version of Grg5,
Grg5DN27, isolated in the yeast two-hybrid screen as a
Runx2-interacting protein, on proteins encoded by three
Runx2 deletion constructs, DN1–48, DN1–94, and
DC516–528 (Fig. 2A). This leads us to hypothesize that
the first 27 amino acid residues of Grg5 may block Grg5
coactivating activity. This blocking activity can be over-
come either by deleting the N-terminal 27 amino acid region
(as in Grg5DN27) or by an interaction requiring both the N-
and C-terminal regions of Runx2. The N-terminal 27 amino
acid residues in Grg5 may function as a specific activation
or interaction ‘‘switch’’. Alternatively, its nonspecific
interference with activation of Runx2 lacking N- or C-
terminal regions may be nonspecific. Further studies are
clearly needed to address these possibilities.
Effects of Runx2 and Grg5 deficiency on body weight and
skeletal growth
Patients with cleidocranial dysplasia, heterozygous for
loss-of-function mutations in Runx2, tend to have a short
stature, and Runx2 null mice are notably smaller than their
heterozygous and wild-type littermates. Runx2+/ Grg5+/+
mice in this study gained weight more slowly than their wild-
type littermates during the first 6 weeks after birth (Fig. 3). It
has already been documented that Grg5 null mice have a
growth delay (see also Fig. 3) which in about 50% of the
mice results in a runted phenotype (Wang et al., 2002), while
growth curves for heterozygous Grg5+/ mice were indis-
tinguishable from those of wild-type mice. The growth
curves clearly indicate that the combination of heterozygous
loss of Runx2 activity and complete lack of Grg5 function
results in a growth deficiency that is greater than would be
expected if Runx2 and Grg5 contributed independently to
growth. This compound genotype caused a severe growth
plate abnormality that likely contributed to the reduced size
and density of the skeleton in the mutant mice.
We do not wish to imply that the effects of Grg5
deficiency on the overall growth and on the skeleton are
entirely secondary to a reduction in the activity of Runx2.
Grg5 is ubiquitously expressed and has been shown to bind
Tcfs in vitro and regulate their activities (Brantjes et al.,
2001; Cavallo et al., 1998; Roose et al., 1998). In addition,
Grg5 deficiency has been reported to cause pituitary abnor-
malities and growth insufficiency based on the loss of its
normal interaction with Tcf4 (Brinkmeier et al., 2003).Therefore, the effects described here on overall growth,
skeletal growth, and growth plate structure are likely to
involve relatively complex mechanisms. For example, be-
cause Tcf4 has shown to be expressed in hypertrophic
chondrocytes and Lef1 by cells in the perichondrium (Hart-
mann and Tabin, 2000), Grg5 may modulate the activity of
Tcf4/Lef1 in osteoblasts and chondrocytes. Furthermore,
Wnt molecules, such as Wnt5a and Wnt5b, are known to
play important roles in chondrocyte proliferation and differ-
entiation in growth plates (Hartmann and Tabin, 2000; Yang
et al., 2003); and it is likely that Tcf4/Lef1 represents
downstream targets in these Wnt signaling pathways
(Huelsken and Birchmeier, 2001). Therefore, Grg5 may
function in chondrocytes of long bone growth plates as a
versatile coactivator of various transcription factors includ-
ing Runx2 and Tcf4.
The reduced activity of Runx2 in the absence of Grg5
leads to proliferative and hypertrophic zones of reduced
height in postnatal growth plates of Runx2+/ Grg5/ mice
(Fig. 5). Although Runx2 null embryos have short limbs,
Runx2 effects on chondrocyte proliferation have not been
clearly established (Inada et al., 1999; Kim et al., 1999). Our
data indicate that Runx2 unquestionably plays a role in
controlling chondrocyte proliferation. Interestingly, the rest-
ing zone of the growth plates in Runx2+/ Grg5/ mice
was expanded (Fig. 5). This increased ‘‘reserve’’ of chon-
drocytes may explain why the overall growth of Runx2+/
Grg5/ mice somehow recovered with age (Fig. 5). What
triggers this recovery is not known, but we speculate that
estrogen–estrogen receptor (ER) signaling may contribute
to this recovery concomitant with sexual maturation. The
growth rates of the female Grg5 null (Runx2 wild-type) and
Runx2+/ Grg5/ mice were higher than those of wild-type
mice after 4–5 weeks of age, whereas the male Grg5 null
(Runx2 wild-type) and Runx2+/ Grg5/ mice maintained
similar or even lower growth rates (Fig. 3). Estrogen
receptor-a (ERa) is present in both osteoblasts and chon-
drocytes (Nilsson et al., 2002; Riggs et al., 2002). Estrogen
treatment of osteoblastic cells in culture enhances Runx2
expression. The nuclear steroid receptor ERa interacts with
Runx2 when their DNA binding sites are in proximity
(McCarthy et al., 2003). Furthermore, high levels of estro-
gen in mice increase the number of Runx2-positive osteo-
blasts (Plant and Tobias, 2001, 2002; Plant et al., 2002).
Conversely, ERa null mice have shorter and smaller long
bones than wild-type mice (Couse and Korach, 1999; Hewitt
and Korach, 2002; Vidal et al., 2000; Weise et al., 2001).
Ihh is a target of Runx2 in growth plate chondrocytes
Ihh is a major regulator of bone development and growth.
It coordinates chondrocyte proliferation, chondrocyte differ-
entiation, and osteoblast differentiation (Kronenberg, 2003).
Several lines of evidence suggest that Ihh in the prehyper-
trophic chondrocytes is a target of Runx2 in growth plates.
First, no Ihh expression is detected in chondrocytes of
W.F. Wang et al. / Developmental Biology 270 (2004) 364–381 379proximal limb cartilages in Runx2 null mice, and the
expression of Ihh is markedly reduced in the distal limbs
where chondrocyte hypertrophy occurs (Inada et al., 1999;
Kim et al., 1999). Second, overexpression of Runx2 in
chondrocytes prematurely induces Ihh expression in ribs
and promotes chondrocyte hypertrophy (Takeda et al., 2001;
Ueta et al., 2001). Third, Runx2 expression in chondrocytes
is maintained in Ihh null mice (St-Jacques and Hammersch-
midt, 1999). Furthermore, Runx2 mRNA is upregulated in
prehypertrophic chondrocytes where Ihh expression is lo-
calized. The results of the present study suggest that the
Grg5 effect on Ihh expression is mediated by Runx2.
Reduced Runx2 activity (Runx2+/) in the absence of
Grg5 leads to severely reduced Ihh expression and signaling
in growth plates compared with mice with Runx2 deficiency
and normal Grg5 function. The precise pathway for Runx2
control of Ihh expression in growth plate chondrocytes
awaits further study.
In summary, we have provided in vitro and in vivo
evidence that Grg5 interacts with Runx2 and acts as a
positive regulator of Runx2. A severe postnatal growth
defect is seen in Runx2+/ Grg5/ mice that is correlated
with defects in both membranous and endochondral bone
formation. The long bones have growth plate defects with
narrowed proliferative and hypertrophic zones and expanded
resting zones. These defects are associated with reduced Ihh
expression and reduced Ihh signaling. We conclude that
reduced Runx2 activity in the absence of Grg5 activity in
the chondrocytes of growth plate leads to defects caused by
reduced Ihh expression.Acknowledgments
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